A company on the verge of bankruptcy would not see a day like today.
That statement is not only wrong it proves for shareholders that believe it an ignorance of the OTC market to which Cytodyn belongs.
It is VERY common in the OTC world to have stocks jumping much more than that, even RIGHT AFTER a bankruptcy is announced. Pure greed and speculation at play.
Yet the shareholders still end up ruined when the music stops.
Insider Financial really crossing the line of "journalism" with that piece insinuating that GSK and CYDY are close to a deal. Clearly a dump is on the way given the article and price action. Who will be buying today close to .60 when history has shown it will be cut in half 30 days for now. Or another "article" to hype the shareholders to dupe them to vote yes for another 350,000,000 shares.